A
Mersana Therapeutics Inc 840 Memorial Drive Category: Biotechnical Research, Commercial |
Company representatives
Julie Olson, Cio/Cto
C Boyd Clarke, Chairman
Nicholas G Bacopoulos, President & Chief Executive Officer
Location Type
Single Location
Revenue
$12,500,000 - $15,000,000
Employees
10 to 19
Years In Business
21
State of incorporation
Massachusetts
SIC code
283404 (Drug Millers (Mfrs))
NAICS code
325412 (Pharmaceutical Preparation Manufacturing)
Rating
Browse U.S. states for Biotechnical Research, Commercial
